Market Data
Supply chain trends, testing adoption rates, and category breakdowns for the U.S. peptide research market — updated quarterly.
$2.1B+
U.S. Market Size
Total estimated domestic peptide supply market
340+
Compounds Tracked
Across all 6 research categories
61%
COA-Verified Suppliers
Up from 34% in 2024
38
Facilities on Import Alert
Import Alert 66-40 expansion (May 2026)
Domestic vs. Import Sourcing Trends
Quarterly tracking of domestic vs. imported peptide API sourcing volume across the U.S. market. Import Alert 66-40 expansion (May 2026) marked.
API Sourcing Mix — Domestic vs. Imported (%)
Q1 2025 – Q2 2026Import Alert 66-40 expansion (May 2026) drove sharp shift to domestic sourcing in Q2 2026.
Supply Chain Trend Indicators
+47%
Domestic API Sourcing Inquiries
Quarter-over-quarter increase since Import Alert 66-40 expansion
16–20 wks
Average Domestic Supplier Lead Time
Up from 6–8 weeks pre-alert; capacity constraints emerging
$340M+
Domestic Capacity Investment (2026)
Announced facility and equipment investments across 4+ manufacturers
10–14 wks
Supplier Qualification Timeline
Compressed from 16–32 weeks as facilities expedite domestic alternatives
COA Verification Adoption by Category
Percentage of tracked suppliers in each category providing independent third-party Certificate of Analysis documentation. Industry average: 61%.
Category Market Share
Metabolic Research
Recovery & Healing
Growth Factor
Cosmetic & Longevity
Cognitive Research
Compounding
Downloadable Intelligence Reports
The 2026 Peptide Supply Chain Report
Comprehensive analysis of domestic vs. import sourcing trends, Import Alert 66-40 impact assessment, and domestic capacity investment outlook through 2028.
The 2026 COA Verification Standards Report
Industry-wide COA verification adoption rates by category, third-party testing laboratory landscape, and emerging verification framework standards.
Reports are free for registered subscribers. Sign in or create an account to access full reports.